Home/ Stocks/ XLO

Xilio Therapeutics, Inc. Common Stock

XLO XNAS

$7.74 -0.07 (-0.90%) ▼ 15-min delayed

Open

$7.75

High

$7.91

Low

$7.60

Volume

22.9K

Market Cap

$46.31M

About Xilio Therapeutics, Inc. Common Stock

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 76 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$43.77M	$-35,036,000	$-4.19
FY 2025	$43.77M	$-35,036,000	$-4.19
Q3 2025	$19.07M	$-16,287,000	$-0.11
Q2 2025	$8.08M	$-15,844,000	$-0.16

Related Market News

No specific coverage for XLO yet. Check out our latest market news or earnings calendar.

Get XLO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Xilio Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.